Baxdrostat, which AstraZeneca acquired in a 2023 buyout of CinCor Pharma, could become a new treatment for people whose hypertension is either uncontrolled by or resistant to existing medicines.

NEW YORK – QuidelOrtho announced Monday an integration deal making fecal biomarker testing from Bühlmann Laboratories available on QuidelOrtho's Vitros system. The Bühlmann fecal tests detect ...

Titer tests are what's used "to help you determine if you currently have immunity to certain diseases due to past infection or vaccination,” says Dr. Alison Mitzner, a New York board-certified ...

Quest Diagnostics has signed up to offer a blood test that can help diagnose Alzheimer’s disease, following its FDA clearance earlier this year. | The Lumipulse G blood test measures the ratio between ...

Quest will offer the first FDA-approved blood test to help detect Alzheimer’s-related amyloid pathology in patients with ...

Quest Diagnostics to offer US FDA-approved Fujirebio blood test for Alzheimer's disease: Secaucus, New Jersey Friday, July 11, 2025, 14:00 Hrs [IST] Quest Diagnostics, a leader in ...

Plasma proteomics reveals that the biological ages of key organs, especially the brain and immune system, strongly predict ...

Researchers are making ever more sophisticated mini organs in the lab — and now they can grow their own blood vessels. The ...

Berkeley scientists have developed a smartphone-based biosensor that mimics coffee-ring physics to detect disease proteins ...

Researchers at the Federal University of São Carlos (UFSCar) in the state of São Paulo, Brazil, are developing a panel of ...

Don't miss out on these blood tests that provide critical medical information to your health care providers.